Iovance Biotherapeutics Stock Rises 33% After Raising FY26 Total Revenue Outlook

(RTTNews) - Shares of Iovance Biotherapeutics, Inc.

(IOVA) are gaining about 33 percent on Tuesday morning after the company announced its decision to raise its full year 2026 total revenue guidance range to $410 to $420 million, driven by strong U.